封面
市場調查報告書
商品編碼
1844027

第二皮膚診斷:創新與成長機會,2025-2029年

Second Skin Diagnostics: Innovations and Growth Opportunities, 2025-2029

出版日期: | 出版商: Frost & Sullivan | 英文 30 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

穿戴式診斷貼片徹底改變非侵入性健康監測,能夠即時檢測生物標記以實現個人化護理。

「第二皮膚」診斷技術是指一類新興的超薄軟性生物感測器,目的是無縫貼合皮膚,並持續即時監測各種生理訊號。這類穿戴式裝置採用可拉伸的類皮膚材料製成,透過與汗水和皮膚的非侵入式接觸,可以追蹤生命徵象和生物標記,例如體溫、水分、血糖和心率。這些設備配備無線通訊功能,目的是提供舒適性、長期使用,並可整合到遠端健康監測系統中。

本報告深入分析了新興的「第二皮膚」診斷領域,重點關注用於疾病診斷的微流體和生物電子貼片。報告考察了這些領域的技術格局、市場準備、相關人員活動和創新模式。報告還全面分析了支持「第二皮膚」診斷開發的全球合約開發和受託製造廠商(CDMO)格局,包括感測器、黏合劑、微流體和電池組件。報告還指出了「第二皮膚」診斷的關鍵成長機會,重點介紹了新技術、整合潛力以及可能將「第二皮膚」診斷從輔助工具發展成為獨立診斷解決方案的市場推動因素。

本報告探討了「第二皮膚」診斷技術如何改變醫療保健。這些創新解決方案結合了微流體、軟性電子產品和生物感測器,為傳統診斷方法提供了非侵入式的替代方案。

本報告檢驗了這項技術如何將診斷從實驗室轉移到皮膚,提高可及性,加快結果並支持更個人化的護理。

了解 第二皮膚診斷 如何為分散式、患者友善的醫療保健鋪平道路。

目錄

戰略問題

  • 為何成長變得越來越困難?
  • The Strategic Imperative 8
  • 三大策略挑戰對第二皮膚診斷產業的影響
  • 加速成長機會成長管道引擎
  • 調查方法

成長機會分析

  • 分析範圍
  • 區隔
  • 皮膚及其在診斷中的作用
  • 第二皮膚診斷的重大產業轉變

成長要素

  • 成長動力
  • 成長抑制因素

生物電子第二皮膚診斷:技術分析

  • 涉足生物電子第二皮膚診斷的主要企業
  • 參與生物電子第二皮膚診斷的主要學術公司
  • 技術和相關人員分析:生物電子第二皮膚診斷

微流體第二皮膚診斷:技術分析

  • 參與微流體第二皮膚診斷的主要企業
  • 參與微流體第二皮膚診斷的領先學術公司
  • 技術和相關人員分析:微流體第二皮膚診斷

相關人員活動:對資金籌措、夥伴關係和收購的見解

  • 第二皮膚診斷專利分析
  • 為第二皮膚診斷進行私人資金籌措
  • 第二皮膚診斷領域的公共資金籌措活動
  • 第二皮膚診斷 建立策略夥伴關係關係
  • 分析師對第二皮膚診斷相關人員活動的洞察

為每個CDMO實現第二皮膚診斷

  • 先進的皮膚介面材料和貼片技術提供商
  • 全球第二皮膚診斷CDMO及CDRO狀況(依地區)
  • 感測器和印刷電子CDMO和CDRO引領第二皮膚診斷領域

第二個皮膚診斷的成長機會

  • 成長機會1:與基於人工智慧的預測診斷結合
  • 成長機會2:多模態感測貼片
  • 成長機會3:與數位健康生態系的整合

附錄

  • 技術完備等級(TRL):描述

後續步驟

  • 成長機會的益處和影響
  • 後續步驟
  • 免責聲明
簡介目錄
Product Code: DB2E

Wearable diagnostic patches are revolutionizing non-invasive health monitoring, enabling real-time detection of biomarkers for personalized care

Second skin diagnostics refers to the emerging class of ultra-thin, flexible biosensors designed to adhere seamlessly to the skin and continuously monitor a range of physiological signals in real time. Made from stretchable, skin-like materials, these wearables can track vital signs and biomarkers, such as temperature, hydration, glucose, and heart rate, through non-invasive contact with sweat or skin. Equipped with wireless communication capabilities, these devices are designed for comfort, long-term use, and integration into remote health monitoring systems.

This report provides an in-depth analysis of the emerging field of second skin diagnostics, focusing on microfluidic and bioelectronic patches used for disease diagnosis. It examines the technological landscape, market readiness, stakeholder activities, and innovation patterns in these segments. The report also offers a comprehensive analysis of the global contract development and manufacturing organization (CDMO) landscape supporting second skin diagnostics development on sensors, adhesives, microfluidics, or battery components. It also identifies the key growth opportunities in second skin diagnostics, focusing on emerging technologies, integration potential, and market enablers that can drive second skin diagnostics from an adjunct tool to standalone diagnostic solutions.

Our latest report explores how second skin diagnostics are transforming the healthcare landscape. By combining microfluidics, flexible electronics, and biosensors, these innovative solutions offer a non-invasive alternative to traditional diagnostic modalities.

The report examines how this technology is shifting diagnostics from the lab to the skin - improving accessibility, speeding up results, and supporting more personalized care.

Discover how second skin diagnostics are paving the way for decentralized, patient-friendly healthcare.

Table of Contents

Strategic Imperatives

  • Why Is It Increasingly Difficult to Grow?
  • The Strategic Imperative 8
  • The Impact of the Top 3 Strategic Imperatives on the Second Skin Diagnostics Industry
  • Growth Opportunities Fuel the Growth Pipeline Engine
  • Research Methodology

Growth Opportunity Analysis

  • Scope of Analysis
  • Segmentation
  • Skin and its Role in Diagnostics
  • Key Industry Shifts in Second Skin Diagnostics

Growth Generator

  • Growth Drivers
  • Growth Restraints

Bioelectronic Second Skin Diagnostics: Technology Analysis

  • Key Players Involved in Bioelectronic Second Skin Diagnostics
  • Key Academic Players Involved in Bioelectronic Second Skin Diagnostics
  • Technology and Stakeholder Analysis: Bio-electronic Second Skin Diagnosis

Microfluidic Second Skin Diagnostics: Technology Analysis

  • Key Players Involved in Microfluidic Second Skin Diagnostics
  • Key Academic Players Involved in Microfluidic Second Skin Diagnostics
  • Technology and Stakeholder Analysis: Microfluidic Second Skin Diagnostics

Stakeholder Activities: Insights on Funding, Partnerships, and Acquisitions

  • Patent Analysis for Second Skin Diagnostics
  • Private Funding Activities in Second Skin Diagnostics
  • Public Funding Activities in Second Skin Diagnostics
  • Strategic Partnerships Shaping Second Skin Diagnostics
  • Analyst Insights on the Stakeholder Activities of Second Skin Diagnostics

Enabling Second Skin Diagnostics with CDMOs

  • Advanced Skin-interfacing Materials & Patch Technology Providers
  • Global Landscape of CDMO and CDRO for Second Skin Diagnostics, by Region
  • Sensors and Printed Electronics CDMOs and CDROs Lead the Second Skin Diagnostic Landscape

Growth Opportunity Universe in Second Skin Diagnostics

  • Growth Opportunity 1: Integration with AI-driven Predictive Diagnostics
  • Growth Opportunity 2: Multimodal Sensing Patches
  • Growth Opportunity 3: Integration with Digital Health Ecosystems

Appendix

  • Technology Readiness Levels TRL: Explanation

Next Steps

  • Benefits and Impacts of Growth Opportunities
  • Next Steps
  • Legal Disclaimer